Results 111 to 120 of about 147,528 (279)

A case of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma

open access: yesJEADV Clinical Practice
A 65‐year‐old Japanese woman with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma, a rare type with a poor prognosis, is presented.
Tomomichi Shimizu   +9 more
doaj   +1 more source

T-Cell Lymphoblastic Lymphoma with Cutaneous Involvement in a Child: A Rare Case Report

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Jiaoquan Chen,* Xin Tian,* Nanji Yu, Liqian Peng, Huilan Zhu Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of China*These authors contributed equally to this workCorrespondence: Huilan Zhu,
Chen J, Tian X, Yu N, Peng L, Zhu H
doaj  

Cutaneous T-Cell Lymphomas [PDF]

open access: yesJAMA Dermatology, 2017
Julia Dai, Timothy Almazan, Youn H. Kim
openaire   +3 more sources

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Zosteriform Primary Cutaneous Marginal Zone Lymphoma—A Case Report

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.
Natalie Teh   +4 more
wiley   +1 more source

Bilateral Periareolar Nodules in an Adolescent With a History of Lymphoma

open access: yes
JEADV Clinical Practice, EarlyView.
Rawan Almutairi   +5 more
wiley   +1 more source

Anaplastic large cell lymphoma in children and adolescents

open access: yesBritish Journal of Haematology, EarlyView.
Summary Anaplastic lymphoma kinase (ALK)‐positive anaplastic large‐cell lymphoma (ALCL) accounts for >95% of ALCL cases in children and adolescents. The first description of ALCL as a CD30‐positive lymphoma in 1985 was followed by the detection of chromosomal translocations involving the ALK gene at chromosome 2p23.
Eric J. Lowe, Wilhelm Woessmann
wiley   +1 more source

Copanlisib in combination with rituximab and bendamustine for transplant‐ineligible relapsed/refractory diffuse large B‐cell lymphoma patients: Results from the phase II multicentre FIL Copa‐BR trial from Fondazione Italiana Linfomi (FIL)

open access: yesBritish Journal of Haematology, EarlyView.
A phase II, single‐arm, multicentre trial was conducted by Fondazione Italiana Linfomi (FIL) to investigate the combination of copanlisib plus rituximab and bendamustine (copa‐BR) in transplant‐ and chimeric antigen receptor (CAR)‐T‐ineligible relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL). Thirty‐seven patients were enrolled.
Mattia Novo   +24 more
wiley   +1 more source

Breast implant-associated anaplastic large cell lymphoma: A review and assessment of cutaneous manifestations

open access: yesInternational Journal of Women's Dermatology, 2017
One newly recognized form of T-cell lymphoma is breast implant-associated anaplastic large cell lymphoma (biALCL), which appears in close proximity to breast implants. The number of reported cases of biALCL is increasing and warrants careful attention by
N. Shahriari, MD   +2 more
doaj  

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1980
B. Poiesz   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy